Immediate Impact
3 by Nobel laureates 51 standout
Citing Papers
Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
2023 Standout
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021 Standout
Works of C. Hézode being referenced
68 Daily cannabis smoking as a risk factor for fibrosis progression in chronic hepatitis C
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| C. Hézode | 260 | 240 | 53 | 36 | 291 | |
| Liliana Preoțescu | 151 | 199 | 109 | 23 | 331 | |
| Monica Schiavini | 210 | 218 | 86 | 22 | 306 | |
| Amy Puenpatom | 156 | 153 | 109 | 39 | 284 | |
| Kayoko Naiki | 224 | 208 | 64 | 23 | 302 | |
| Dragan Delić | 242 | 262 | 38 | 44 | 335 | |
| Margarita Dehesa-Violante | 155 | 172 | 28 | 24 | 303 | |
| Mohamed AbdAllah | 235 | 233 | 43 | 37 | 316 | |
| Céline Dorival | 138 | 141 | 18 | 28 | 215 | |
| Christiana Graf | 141 | 169 | 49 | 32 | 314 | |
| Kaoru Suzuki | 118 | 129 | 42 | 34 | 329 |
All Works
Loading papers...